RA Capital Healthcare Fund was down 7.8% for March and 4.7% for the first quarter. The healthcare-focused fund invests in both public and private companies that are developing drugs, medical devices and diagnostics. The fund's long equity positions detracted 7.5% in March and 6% for the quarter. Total privates detracted 2.2% for March and 0.5% for the quarter. Shorts added 2.5% for March and 3.3% for the quarter.
Q1 2020 hedge fund letters, conferences and more
Beyond COVID-19 treatments
In his March letter to investors, Michael Calore said while COVID-19 has significantly disrupted the markets and daily life, progress is still being made in other areas of biotech. He said they...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
